Macular Degeneration News

ThromboGenics’ Microplasmin Phase III Program Progressing According To Schedule

ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its lead product microplasmin, which is in Phase III trials for the treatment of vitreomacular adhesion, is progressing according to schedule. All protocol-specified, interim masked analyses by the independent Data Monitoring Committee (DMC) have been completed.

Original post by macular degeneration – Google News

(click on the author link above to see full post)

Vitamins Slow Eye Degeneration in Senior Citizens – Natural News.com

TheMedGuru

Vitamins Slow Eye Degeneration in Senior CitizensNatural News.com(NaturalNews) A specific combination of vitamins and other nutrients may significantly slow down the rate of sight loss in Age-Related Macular Degeneration …Macular degeneration, vision lossShelby Township Source NewspapersPreventing eye diseaseBradenton HeraldCarrot helps improve vision: StudyTheMedGuruEurekAlert (press release)all 14 news articles »

Original post by macular degeneration – Google News

(click on the author link above to see full post)

Acucela’s Novel Visual Cycle Modulator Demonstrates Promise As A Treatment For Dry Age-Related Macular Degeneration (Medical News Today)

Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that data on the company’s novel visual cycle modulator, ACU-4429, a potential oral treatment for dry age-related macular degeneration (AMD), will be featured at the Aegean Retina XI Meeting being held in Crete, Greece from July 3 to 5, 2009.

Original post by macular degeneration – Google News

(click on the author link above to see full post)

Acucela’s Novel Visual Cycle Modulator Demonstrates Promise As A Treatment For Dry Age-Related Macular Degeneration

Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that data on the company’s novel visual cycle modulator, ACU-4429, a potential oral treatment for dry age-related macular degeneration (AMD), will be featured at the Aegean Retina XI Meeting being held in Crete, Greece from July 3 to 5, 2009.

Original post by macular degeneration – Google News

(click on the author link above to see full post)

Canon U.S.A. Introduces The CR-1 Mark II Digital Non-Mydriatic Retinal Camera For Eyecare Professionals

Adding to its line up of complete total digital imaging and workflow management solutions for eyecare professionals, Canon U.S.A., Inc., a leader in medical imaging, today introduced the CR-1 Mark II Digital Non-Mydriatic Retinal Camera. The CR-1 Mark II can achieve extremely detailed, high-resolution diagnostic images of the retina and enables a full 45-degree view angle to help the eyecare professional detect and monitor ocular conditions.

Original post by macular degeneration – Google News

(click on the author link above to see full post)

New Glaucoma Treatment To Be Piloted, Wales

New ways of diagnosing and treating patients with glaucoma will be piloted in two areas in Wales, Health Minister Edwina Hart announced today. The ophthalmic diagnostic centre pilot will evaluate the feasibility of diagnosing and monitoring of glaucoma by optometrists working in the community, supported by hospital consultants. Subject to the outcome of the pilot, plans will be developed to roll it out across Wales.

Original post by macular degeneration – Google News

(click on the author link above to see full post)

Health screenings every man should consider

Men are less likely to visit a doctor regularly, compared to women, and often wait until a health issue becomes serious before seeking medical attention.

Original post by Examiner.com

(click on the author link above to see full post)

CBS Loses its Longest-Serving Staffer

Anne Roberts Nelson, who spent more than 60 years at the Eye network, has passed away.

Original post by Television Week

(click on the author link above to see full post)

Volunteers Needed For QUT Eye Study, Australia

A Queensland University of Technology researcher is calling for volunteers to take part in a project examining the role of childhood visual experience on eye growth. Stephen Vincent, a practising optometrist, is conducting the research as part of his PhD and will spend the next 12 months examining volunteers with specific eye conditions such as amblyopia (lazy eye) and strabismus (turned eye).

Original post by macular degeneration – Google News

(click on the author link above to see full post)

Center For Vision Restoration Of UPMC And Pitt Receives Multi-Million Dollar Gift To Be Matched By UPMC

The Center for Vision Restoration of UPMC and the University of Pittsburgh today announced a $3 million gift from Louis J. Fox, a Pennsylvania native and Pitt graduate. UPMC has pledged to match Mr. Fox’s donation to the Center. Mr. Fox, a retired commodity merchant banker and trader, has embraced the Center’s mission to discover cures for blindness and vision impairment through a joint program of the UPMC Eye Center and McGowan Institute for Regenerative Medicine.

Original post by macular degeneration – Google News

(click on the author link above to see full post)